Cart summary

You have no items in your shopping cart.

Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab)

Catalog Number: orb1818441

DispatchUsually dispatched within 5-10 working days
$ 600.00
Catalog Numberorb1818441
CategoryAntibodies
DescriptionRecombinant Antibody
ClonalityMonoclonal
Tested applicationsELISA, FC
ReactivityHuman, Mouse, Rat
IsotypeIgG1
Antibody TypePrimary Antibody
Concentration1mg/ml
Form/AppearancePurified monoclonal antibody supplied in PBS, pH 6.0, without preservative.This antibody is purified through a protein A column.
ConjugationUnconjugated
MW145.44
UniProt IDP04626
Protein SequenceERBB2 / HER2 / CD340
Expression SystemCHO Cell
Endotoxins< 0.001EU/μg,determined by LAL method.
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Alternative namesReceptor tyrosine-protein kinase erbB-2, 2.7.10.1,
Read more...
NoteFor research use only
Expiration Date12 months from date of receipt.
Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab)

The purity of Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab) is more than 99.02%, determined by SEC-HPLC.

Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab)

Immobilized human HER2 (23 652) His at 2 µg/mL can bind Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab), EC50=0.01375 µg/mL

Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab)

Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%

Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab)

Pertuzumab+trastuzumab inhibited the tumor growth of NCI-N87 on Balb/c nude mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 73.8% at 5 mpk at D37.

Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab)

BT474 cells were stained with Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC98=0.2994 µg/mL

  • Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab) [orb1806342]

    ELISA,  FA,  FACS,  Kinetics

    Human

    Monoclonal

    Unconjugated

    50 μg, 100 μg, 1 mg, 5 mg